OROS Methylphenidate in Adolescents with ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-20-1-6

OROS Methylphenidate in Adolescents with ADHD

Pediatric Neurology Briefs

Volume 20 (2006): Issue 1

By: J Gordon Millichap

Open Access

|Jan 2006

Abstract

The efficacy and tolerability of osmotic-release oral system (OROS) methylphenidate in adolescents with attention deficit hyperactivity disorder (ADHD) were evaluated in a multisite controlled study at the Massachusetts General Hospital, Boston, and other centers in the United States.

References

Wilens TE McBurnett K Bukstein O McGough J Greenhill L Lerner M Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder Arch Pediatr Adolesc Med Jan 2006 160 1 82 90 10.1001/archpedi.160.1.82 16389216
Open DOI Search in Google Scholar Back to article
Grizenko N Kovacina B Amor LB Schwartz G Ter-Stepanian M Joober R Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families J Am Acad Child Adolesc Psychiatry Jan 2006 45 1 47 53 10.1097/01.chi.0000184932.64294.d9 16327580
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-20-1-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 6 - 6

Published on: Jan 1, 2006

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Osmotic-Release Oral System,

Attention Deficit Hyperactivity Disorder,

Methylphenidate

© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2006): Issue 1